texture

Cost-effective solutions for biological and cellular therapeutics

Stemmatters is a fully integrated CDMO operating in human cell and tissue products, advanced cell therapies, and other complex biologicals.

contract
development

Stemmatters provides product, process, and analytical method development and validation services tailored to each client’s specific requirements.

  • Taking a therapeutic asset from discovery to market is a complex challenge for any organisation, and therapies such as cell and tissue-based biologicals face additional barriers...
    /Learn more
  • Engineering a robust, scalable and reproducible manufacturing process is a challenging task....
    /Learn more
  • Robust and validated product and process analytics are at the heart of product quality programmes...
    /Learn more
image image image
contract
manufacturing

Stemmatters offers services to develop and implement procedures for isolation and banking of a large variety of human cells.

Cell Therapy

Stemmatters provides manufacturing of cell-based advanced therapy medicinal products...

Biopharmaceuticals

Stemmatters is very well acquainted with the production of biological blood-derived products across all segments of the supply chain...

Quality Control

Quality assurance and control is central to patient safety, product performance, regulatory compliance and ultimately commercial success...

Cell Banking

Cell banking provides integrity of a cell population and assures that cells are readily available for subsequent application...

Aseptic Filling & Storage

Stemmatters offers semi-automated or manual fill & finish operations in a sterile environment.
slide-image
slide-image
slide-image
slide-image
slide-image
news & events

Follow the latest news, events where we are present and press releases...

    • Events
    Stemmatters is attending BIO Digital 2020, held online.
    • Events
    Stemmatters is attending ISCT Paris Virtual 2020 conference.
    • Events
    Stemmatters is attending the RESTORE conference in Berlin.